A Comparison of Once a Day Dose Compared to 2 Doses/Day
NCT00505778
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1027
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
Mesalamine Once-Daily
DRUG:
Mesalamine Twice-Daily
Sponsor
Warner Chilcott